Found 3 of ic50 for monomerid = 202399 TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Cancer Therapeutics Crc Pty
US Patent
Cancer Therapeutics Crc Pty
US Patent
Affinity DataIC50: 8nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Cancer Therapeutics Crc Pty
US Patent
Cancer Therapeutics Crc Pty
US Patent
Affinity DataIC50: 17nMpH: 7.2 T: 2°CAssay Description:Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Cancer Therapeutics Crc Pty
US Patent
Cancer Therapeutics Crc Pty
US Patent
Affinity DataIC50: 6.61E+3nMpH: 7.2 T: 2°CAssay Description:Adult human umbilical vein endothelial cells (HUVEC) (Cat# CC-2519,
Lonza) were seeded into clear-bottom, TC treated 12 well plates (Cat
#665180, G...More data for this Ligand-Target Pair
